BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 33901815)

  • 41. Genetic reprogramming of cord blood derived endothelial colony forming cells towards human induced pluripotent stem cells using episomal plasmids.
    Shahid O; Shamim S; Ainuddin JA; Wahid M
    J Pak Med Assoc; 2021 Apr; 71(4):1081-1088. PubMed ID: 34125747
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Derivation of Clinical-Grade Induced Pluripotent Stem Cell Lines from Erythroid Progenitor Cells in Xenofree Conditions.
    Singh G; Manian KV; Premkumar C; Srivastava A; Daniel D; Velayudhan SR
    Methods Mol Biol; 2022; 2454():775-789. PubMed ID: 33950379
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An integration-free iPSC line SDQLCHi025-A from a girl with multiminicore disease carrying compound heterozygote mutations in RYR1 gene.
    Zhang H; Ma Y; Lv Y; Wan Y; Zhao Q; Gai Z; Liu Y
    Stem Cell Res; 2020 May; 45():101775. PubMed ID: 32272370
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A Rapid and Highly Efficient Method for the Isolation, Purification, and Passaging of Human-Induced Pluripotent Stem Cells.
    Gao X; Sprando RL; Yourick JJ
    Cell Reprogram; 2018 Oct; 20(5):282-288. PubMed ID: 30204478
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Induced pluripotency and spontaneous reversal of cellular aging in supercentenarian donor cells.
    Lee J; Bignone PA; Coles LS; Liu Y; Snyder E; Larocca D
    Biochem Biophys Res Commun; 2020 May; 525(3):563-569. PubMed ID: 32115145
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Generation and characterization of human induced pluripotent stem cells lines from four patients diagnosed with schizophrenia and one healthy control.
    Stock R; Vogel S; Mau-Holzmann UA; Kriebel M; Wüst R; Fallgatter AJ; Volkmer H
    Stem Cell Res; 2020 Oct; 48():101961. PubMed ID: 32911325
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Generation of integration-free induced pluripotent stem cell lines from four pediatric ADHD patients.
    Grossmann L; Yde Ohki CM; Döring C; Hoffmann P; Herms S; Werling AM; Walitza S; Grünblatt E
    Stem Cell Res; 2021 May; 53():102268. PubMed ID: 33662736
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficient Generation of Non-Integration and Feeder-Free Induced Pluripotent Stem Cells from Human Peripheral Blood Cells by Sendai Virus.
    Ye H; Wang Q
    Cell Physiol Biochem; 2018; 50(4):1318-1331. PubMed ID: 30355953
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reprogramming LCLs to iPSCs Results in Recovery of Donor-Specific Gene Expression Signature.
    Thomas SM; Kagan C; Pavlovic BJ; Burnett J; Patterson K; Pritchard JK; Gilad Y
    PLoS Genet; 2015 May; 11(5):e1005216. PubMed ID: 25950834
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Integration-free reprogramming of human somatic cells to induced pluripotent stem cells (iPSCs) without viral vectors, recombinant DNA, and genetic modification.
    Heng BC; Fussenegger M
    Methods Mol Biol; 2014; 1151():75-94. PubMed ID: 24838880
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Generation and characterization of human induced pluripotent stem cells (iPSCs) from hand osteoarthritis patient-derived fibroblasts.
    Castro-Viñuelas R; Sanjurjo-Rodríguez C; Piñeiro-Ramil M; Hermida-Gómez T; Rodríguez-Fernández S; Oreiro N; de Toro J; Fuentes I; Blanco FJ; Díaz-Prado S
    Sci Rep; 2020 Mar; 10(1):4272. PubMed ID: 32144293
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Enhanced Generation of Integration-free iPSCs from Human Adult Peripheral Blood Mononuclear Cells with an Optimal Combination of Episomal Vectors.
    Wen W; Zhang JP; Xu J; Su RJ; Neises A; Ji GZ; Yuan W; Cheng T; Zhang XB
    Stem Cell Reports; 2016 Jun; 6(6):873-884. PubMed ID: 27161365
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genetic Variability Overrides the Impact of Parental Cell Type and Determines iPSC Differentiation Potential.
    Kyttälä A; Moraghebi R; Valensisi C; Kettunen J; Andrus C; Pasumarthy KK; Nakanishi M; Nishimura K; Ohtaka M; Weltner J; Van Handel B; Parkkonen O; Sinisalo J; Jalanko A; Hawkins RD; Woods NB; Otonkoski T; Trokovic R
    Stem Cell Reports; 2016 Feb; 6(2):200-12. PubMed ID: 26777058
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cell type of origin influences iPSC generation and differentiation to cells of the hematoendothelial lineage.
    Phetfong J; Supokawej A; Wattanapanitch M; Kheolamai P; U-Pratya Y; Issaragrisil S
    Cell Tissue Res; 2016 Jul; 365(1):101-12. PubMed ID: 26893154
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Establishment of Four Induced Pluripotent Stem Cell Lines from CD34+ Hematopoietic Stem and Progenitor Cells from a Patient Diagnosed with an Invasive Lobular Mammary Carcinoma.
    Keller AL; Binner A; Schenke-Layland K; Schmees C
    Stem Cell Res; 2022 Oct; 64():102902. PubMed ID: 36055119
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inducing pluripotency in vitro: recent advances and highlights in induced pluripotent stem cells generation and pluripotency reprogramming.
    Rony IK; Baten A; Bloomfield JA; Islam ME; Billah MM; Islam KD
    Cell Prolif; 2015 Apr; 48(2):140-56. PubMed ID: 25643745
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Establishment of integration-free induced pluripotent stem cells from human recessive dystrophic epidermolysis bullosa keratinocytes.
    Matsumura W; Fujita Y; Nakayama C; Shinkuma S; Suzuki S; Nomura T; Abe R; Shimizu H
    J Dermatol Sci; 2018 Mar; 89(3):263-271. PubMed ID: 29229433
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Generation of a Crigler-Najjar Syndrome Type I patient-derived induced pluripotent stem cell line CNS705 (HHUUKDi005-A).
    Graffmann N; Martins S; Ljubikj T; Matte JC; Bohndorf M; Wruck W; Adjaye J
    Stem Cell Res; 2021 Mar; 51():102167. PubMed ID: 33485181
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Generation of induced pluripotent stem cell lines ICGi021-A and ICGi022-A from peripheral blood mononuclear cells of two healthy individuals from Siberian population.
    Malakhova AA; Grigor'eva EV; Pavlova SV; Malankhanova TB; Valetdinova KR; Vyatkin YV; Khabarova EA; Rzaev JA; Zakian SM; Medvedev SP
    Stem Cell Res; 2020 Oct; 48():101952. PubMed ID: 32805537
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
    Liu Y; Deng W
    Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.